Webinar: HCV in prisons - Targeting elimination

In the battle to eliminate HCV as a public health threat by 2030, prison healthcare is at the forefront.

This webinar, developed and hosted by Alchemie Medical Education, part of the Obsidian Group, brings together three international experts who lead prison-based HCV elimination programmes to share their in-depth knowledge and first-hand experience.

Through four presentations and a panel discussion, the faculty will guide you through the key things to consider when setting up HCV testing and treatment programmes in custodial settings, review international best practice and share inspiring success stories that have yielded real-world results.

Originally hosted live on 24th May 2022

Speakers

Dr Fadi Meroueh

Head of Health Unit, Villeneuve-lès-Maguelone Prison, Montpellier, France; President, Health Without Barriers: The European Federation for Prison Health.

Dr Joaquin Cabezas

Hospital Universitario Marques de Valdecilla, Spain

Rachel Halford

CEO, Hepatitis C Trust, UK

Topics

Planning for success: building the foundations of a micro-elimination programme

Dr Fadi Meroueh

Peer-led elimination

Rachel Halford

Breaking barriers

Dr Fadi Meroueh

Success stories: elimination in action

Dr Joaquin Cabezas

Panel discussion and Q&A

All

Webinar developed and hosted by Alchemie Medical Education, part of the Obsidian Group.

This webinar has been funded by an educational grant from Gilead Sciences, Inc. The sponsor had no influence on speaker selection, agenda or content.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close